22-09-2026 18:06 via medpagetoday.com

Progress in HER2-Positive Gastroesophageal Adenocarcinoma

(MedPage Today) -- After a period of relative inactivity, therapeutic development in HER2-positive gastroesophageal adenocarcinoma (GEA) has evolved rapidly over the past 5 years, establishing a new standard of care that was supplanted by another...
Read more »

Medical Industry news



Pediatric Acute Kidney Injury Cases Increased Tenfold Over Past 25 Years
U.S. Cancer Mortality Declined 35% Since 1991, AACR Report Shows
Trump Administration to Remove 760,000 ACA Enrollees, Claiming Fraud
Study Finds Huge Regional Variability in 'Low-Value' Orthopedic Services for Vets
CDC, Epidemiologists Work on Definition for Measles Deaths
Meta's $17.1 Billion Settlement: A Chance for a Social Media Natural Experiment
The Brain as Two Organs; Epstein-Barr and MS; Indigenous Bolivians and Dementia
Stem Cell Infusion Cut Fractures; Testosterone for Menopause; BMD and Cognition
Rare Congenital TORCH Infections Tied to Greater Autism Risk in Kids
What the 'Hyrox' Incident Reveals About Fecal Incontinence
USPSTF's New Cardiologists; Wrist Nerve Stimulator for Afib; Doc Impaled by Tree
Lindsay Clancy's Lawyer Asks Judge to Investigate Juror Who Wanted to Convict Her
GLP-1 Lawsuits Over Eye Risk; Hospital Oxygen Supply Cut; Top Causes of U.S. Deaths
FDA Staff Find No Major Concerns With Galleri Multicancer Early Detection Test
Desktop versie